The store will not work correctly when cookies are disabled.
1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-5-hexyl-1H-1,2,3-triazole
ID: ALA235577
PubChem CID: 11537891
Max Phase: Preclinical
Molecular Formula: C15H16Cl2F3N3
Molecular Weight: 366.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCc1cnnn1-c1c(Cl)cc(C(F)(F)F)cc1Cl
Standard InChI: InChI=1S/C15H16Cl2F3N3/c1-2-3-4-5-6-11-9-21-22-23(11)14-12(16)7-10(8-13(14)17)15(18,19)20/h7-9H,2-6H2,1H3
Standard InChI Key: UUHYJYZVUFBGMW-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
15.9057 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6907 1.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6940 2.5765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9075 2.8338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4243 2.1662 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5993 2.1672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1912 2.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3669 2.8833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9528 2.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3688 1.4515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1917 1.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1278 2.1687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2958 2.1320 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.1095 2.9935 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.1542 1.3441 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.6068 0.7407 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.6060 3.5952 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.6484 0.7138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1987 0.0991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9414 -0.6847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4916 -1.2995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2344 -2.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7846 -2.6980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 6 1 0
1 2 2 0
9 12 1 0
5 6 1 0
12 13 1 0
12 14 1 0
6 7 2 0
12 15 1 0
2 3 1 0
11 16 1 0
7 8 1 0
7 17 1 0
3 4 2 0
1 18 1 0
8 9 2 0
18 19 1 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 1 0
5 1 1 0
21 22 1 0
10 11 2 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.21 | Molecular Weight (Monoisotopic): 365.0673 | AlogP: 5.72 | #Rotatable Bonds: 6 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 0.75 | CX LogP: 6.26 | CX LogD: 6.26 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.61 | Np Likeness Score: -1.01 |
References
1. Alam MS, Huang J, Ozoe F, Matsumura F, Ozoe Y.. (2007) Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors., 15 (15): [PMID:17544280] [10.1016/j.bmc.2007.05.039] |